American corporations selling of Americans Genetic Data to China should have steep consequences

BGI-RD-China

Important Takeaways:

  • U.S. members of Congress introduced a proposed law called the BIOSECURE Act that would ban the use of tax dollars for the utilization of genetics companies from China that collaborate with the People’s Liberation Army (PLA).
  • This is a good bill, but one must ask: How in the world have we allowed such a practice to continue to this day? Why does the executive branch of the U.S. government need a law for such a common-sense rule that it could have made policy long ago?
  • We should have had an all-of-government, if not all-of-society, effort since at least the Tiananmen Square massacre of 1989 to end reliance on China, especially companies linked to its military. We should most especially have limited the release of genetic data to Beijing.
  • As noted in the House announcement, but not in most of the bill’s mainstream media coverage, the proposed law is in part meant to stop the Chinese Communist Party (CCP) from using U.S. genetic data for malign purposes, including genetic targeting of U.S. citizens with bioweapons.
  • “Beijing Genomics Institute (BGI) collects genetic data of Americans [and] uses it for research with the Chinese military,” said Rep. Mike Gallagher (R-Wis.) in the bill’s announcement. Mr. Gallagher chairs the House Select Committee on the CCP. He introduced the House version of the bill, along with his Democratic co-chair.
  • “The CCP will undoubtedly use the genetic data collected by BGI to further its malign aggression, potentially even to develop a bioweapon used to target the American people,” Mr. Gallagher noted.

Read the original article by clicking here.

Britain says China’s BGI must register prenatal tests by Sept 1

By Reuters Staff

LONDON (Reuters) – China’s largest gene company BGI Group must register its prenatal test with local regulators by Sept. 1 if it wants to keep offering products in Britain, a minister said on Thursday.

A Reuters report found BGI Group developed the tests in collaboration with China’s military and uses them to collect genetic data from millions of women round the world.

However, BGI says it alone produced the NIFTY test, has never shared data for national security or defense purposes, and complies with European privacy laws. Reuters found no evidence BGI violated privacy agreements or regulations.

British junior health minister James Bethell said the British Medicines and Healthcare products Regulatory Agency (MHRA) expected BGI’s devices to need oversight before being placed on the local market.

“The MHRA understand BGI genetic screening tests are currently available for sale in the UK. These devices do not appear to have been registered with the MHRA at this time,” Bethell said in a written response to a question on BGI’s tests from a member of Britain’s upper chamber of parliament.

“However, due to their risk classification, registration will be required from 1 September 2021 in order to continue placing the products on the market.”

Bethell said there had been no specific assessment of BGI’s tests, but that neither the state-run National Health Service (NHS) nor the Public Health England (PHE) agency used its technology.

The tests have been available in some private clinics in England since at least 2014, however.

“There are no grounds to prevent BGI Groups operating in the UK provided they comply with UK legislation and regulatory requirements,” Bethell added.

In an emailed statement, BGI said it “strictly complies with local laws, guidelines, and protocols, while adhering to internationally recognized ethical and legal standards.”